Inhibitory effect of survivin-targeting small interfering RNA on gastric cancer cells

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 6786-6803

  Li, Y H ^a   Chen, M ^a   Zhang, M ^a   Zhang, X Q ^a   Zhang, S ^a   Yu, C G ^a   Xu, Z M ^a   Zou, X P ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Apoptosis; Gastric cancer; Small interfering RNA; Survivin

Indexed keywords

CASPASE 3; CYTOCHROME C; SMALL INTERFERING RNA; SURVIVIN; ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, HUMAN; CISPLATIN; INHIBITOR OF APOPTOSIS PROTEIN; MITOCHONDRIAL PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RNA INTERFERENCE; STOMACH CANCER; UPREGULATION; DRUG RESISTANCE; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; CYTOCHROMES C; DRUG RESISTANCE, NEOPLASM; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICROSCOPY, FLUORESCENCE; MITOCHONDRIAL PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84907146106     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.August.28.22     Document Type: Article

References (35)

1. Altieri DC (2001). The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol. Med. 7: 542-547.
2. Altieri DC (2003a). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22: 8581-8589.
3. Altieri DC (2003b). Validating survivin as a cancer therapeutic target. Nat. Ver. Cancer 3: 46-54.
4. Ambrosini G, Adida C and Altieri DC (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3: 917-921.
5. Brummelkamp TR, Bernards R and Agami R (2002). Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243-247.
6. Caldas H, Holloway MP, Hall BM, Qualman SJ, et al. (2006). Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo. J. Med. Genet. 43: 119-128.
7. Fields AC, Cotsonis G, Sexton D, Santoianni R, et al. (2004). Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Mod. Pathol. 17: 1378-1385.
8. Fortugno P, Wall NR, Giodini A, O'Connor DS, et al. (2002). Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci. 115: 575-585.
9. Kania J, Konturek SJ, Marlicz K, Hahn EG, et al. (2003). Expression of survivin and caspase-3 in gastric cancer. Dig. Dis. Sci. 48: 266-271.
10. Kawasaki H, Altieri DC, Lu CD, Toyoda M, et al. (1998). Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58: 5071-5074.
11. Lee GH, Joo YE, Koh YS, Chung IJ, et al. (2006). Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Eur. J. Gastroenterol. Hepatol. 18: 957-963.
12. Li F, Ambrosini G, Chu EY, Plescia J, et al. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584.
13. Li F, Ackermann EJ, Bennett CF, Rothermel AL, et al. (1999). Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1: 461-466.
14. Li YH, Wang C, Meng K, Chen LB, et al. (2004). Influence of survivin and caspase-3 on cell apoptosis and prognosis in gastric carcinoma. World J. Gastroenterol. 10: 1984-1988.
15. Lu XY and Liu NZ (2004). Expression of Survivin Gene and its relationship with Expression of caspase-3, p53 in Gastric Carcinoma. J. Huazhong Univ. Sci. Technol. 33: 724-725.
16. Ma R, Chen XH, Zhang QF, Zhu L, et al. (2007). Exploration on the increased sensitivity to docetaxel and reversing mechanism of drug resistance of antisense survivin RNA in gastric cancer cell line SGC7901 cells. Zhonghua Zhong Liu Za Zhi 29: 89-92.
17. Miao GY, Lu QM and Zhang XL (2007). Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells. World J. Gastroenterol. 13: 1170-1174.
18. Morinaga S, Nakamura Y, Ishiwa N, Yoshikawa T, et al. (2004). Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Oncol. Rep. 12: 1189-1194.
19. Nakamura M, Tsuji N, Asanuma K, Kobayashi D, et al. (2004). Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients. Cancer Sci. 95: 44-51.
20. Okada E, Murai Y, Matsui K, Isizawa S, et al. (2001). Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett. 163: 109-116.
21. Sarela AI, Verbeke CS, Ramsdale J, Davies CL, et al. (2002). Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br. J. Cancer 86: 886-892.
22. Sommer KW, Schamberger CJ, Schmidt GE, Sasgary S, et al. (2003). Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 22: 4266-4280.
23. Sui L, Dong Y, Ohno M, Watanabe Y, et al. (2002). Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors. Int. J. Oncol. 21: 315-320.
24. Swana HS, Grossman D, Anthony JN, Weiss RM, et al. (1999). Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N. Engl. J. Med. 341: 452-453.
25. Takai N, Miyazaki T, Nishida M, Nasu K, et al. (2002). Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett. 184: 105-116.
26. Tanaka K, Iwamoto S, Gon G, Nohara T, et al. (2000). Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 6: 127-134.
27. Tran J, Master Z, Yu JL, Rak J, et al. (2002). A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc. Natl. Acad. Sci. U. S. A. 99: 4349-4354.
28. Tsuburaya A, Noguchi Y, Yoshikawa T, Saito A, et al. (2002). An anti-apoptosis gene, survivin and telomerase expression in gastric cancer. Hepatogastroenterology 49: 1150-1152.
29. Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, et al. (2005). Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells. Anticancer Res. 25: 3967-3972.
30. Uren AG, Wong L, Pakusch M, Fowler KJ, et al. (2000). Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr. Biol. 10: 1319-1328.
31. Vaira V, Lee CW, Goel HL, Bosari S, et al. (2007). Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene 26: 2678-2684.
32. Van Antwerp DJ, Martin SJ, Verma IM and Green DR (1998). Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol. 8: 107-111.
33. Wakana Y, Kasuya K, Katayanagi S, Tsuchida A, et al. (2002). Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol. Rep. 9: 1213-1218.
34. You L, He B, Xu Z, Uematsu K, et al. (2004). Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 23: 6170-6174.
35. Zaffaroni N, Pennati M, Colella G, Perego P, et al. (2002). Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol. Life Sci. 59: 1406-1412.